|
ZFC3H1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.17479999459403E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.5700000000638E-07 |
| Normal-vs-Stage2 |
1.003360E-03 |
| Normal-vs-Stage3 |
3.339600E-03 |
| Normal-vs-Stage4 |
2.824800E-03 |
| Stage1-vs-Stage2 |
3.409600E-01 |
| Stage1-vs-Stage3 |
2.953400E-01 |
| Stage1-vs-Stage4 |
5.134800E-01 |
| Stage2-vs-Stage3 |
1.365960E-01 |
| Stage2-vs-Stage4 |
2.008800E-01 |
| Stage3-vs-Stage4 |
8.051600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.39510000019794E-07 |
| Normal-vs-AfricanAmerican |
2.597300E-04 |
| Normal-vs-Asian |
2.403600E-02 |
| Caucasian-vs-AfricanAmerican |
1.112450E-01 |
| Caucasian-vs-Asian |
6.530000E-02 |
| AfricanAmerican-vs-Asian |
3.056400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.35480000002164E-06 |
| Normal-vs-Female |
2.13930000048101E-07 |
| Male-vs-Female |
1.895230E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.545600E-01 |
| Normal-vs-Age(41-60Yrs) |
2.73300000408483E-08 |
| Normal-vs-Age(61-80Yrs) |
5.74709999999756E-05 |
| Normal-vs-Age(81-100Yrs) |
1.158650E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.081600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.392600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.673600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.603360E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.319000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.755000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.977300E-03 |
| Normal-vs-Grade 2 |
4.35809999976833E-07 |
| Normal-vs-Grade 3 |
5.53719999999425E-05 |
| Normal-vs-Grade 4 |
1.394310E-02 |
| Grade 1-vs-Grade 2 |
1.047820E-01 |
| Grade 1-vs-Grade 3 |
1.803530E-02 |
| Grade 1-vs-Grade 4 |
4.791900E-02 |
| Grade 2-vs-Grade 3 |
2.343800E-01 |
| Grade 2-vs-Grade 4 |
3.471600E-01 |
| Grade 3-vs-Grade 4 |
8.680400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.72649999963248E-07 |
| Normal-vs-ccB subtype |
3.811500E-04 |
| ccA subtype-vs-ccB subtype |
2.056600E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.56839999998893E-07 |
| Normal-vs-N1 |
1.921000E-01 |
| N0-vs-N1 |
9.363800E-01 |
|
|
